期刊文献+

中医体质调理对高血压病血栓前状态的干预研究 被引量:7

Intervention Research of Control Scheme of TCM Body Constitution on the Pro-thrombotic State (PTS) of Hypertension
下载PDF
导出
摘要 目的:运用中医体质防治方案对高血压病血栓前状态(pro-thrombotic state,PTS)进行早期干预,观察高血压病控制情况、患者生活质量、高血压血栓前状态分子标志物水平及心肌梗死与脑梗死发生率的影响,评价中医体质防治方案对高血压病血栓前状态干预的可行性。方法:体质干预组与西医基础治疗的对照组进行对比研究。结果:体质干预组血压控制情况体质干预组与对照组差异有统计学意义(P<0.05);体质干预组较对照组生活质量改善明显(P<0.05);体质干预组PTS分子标志物水平中vWF、GMP-140、11-DH-TXB2下降显著显,AT升高显著,与对照组比较差异有统计学意义(P<0.05);心肌梗死率及脑梗死率,差异有统计学意义(P<0.05)。结论:中医体质防治方案在高血压病血栓前状态的干预效果显著。 Objective The pro-thrombotic state (PTS) of hypertension was given to early intervention with con- trol scheme of TCM body constitution. And the feasibility of TCM body constitution control scheme on hypertension was evaluated to do intervention to pro-thrombotic state (PTS). Methods: Treatment group was treated by early in- tervention with control scheme of TCM body constitution, and control group was treated by western medicine. The results were compared with. Results: There was signifi 〈 0. 05). So was on the quality of life ( P 〈 0. 05 ). cant difference between the two groups on blood pressure (P In treatment group vWF, GMP-140 and l l-DH-TXB2 de- creased markedly, but AT increased, and significant difference showed up between the two groups on them (P 〈0. 05 ). The difference was also statistically significant between the two groups on the incidence rates of myocardial infarction and cerebral infarction (P 〈 0. 05 ). Conclusion The effect of control scheme of TCM body constitution is good and reliable on the pro-thrombotic state (PTS) of hypertension..
出处 《山西中医》 2013年第3期37-39,共3页 Shanxi Journal of Traditional Chinese Medicine
基金 广西医疗卫生重点科研基金资助项目(编号:重2010086)
关键词 高血压病血栓前状态 中医体质 早期干预 临床研究 the pro-thrombotic state (PTS) of hypertension, the body constitution of TCM, early intervention
  • 相关文献

参考文献6

二级参考文献33

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2Qizilbash N,Duffy S,Prentice CRM,et al.yon Willebrand factor and risk of ischemic stroke[J].Neurology,2001,53 (6):1 552.
  • 3Lip GY,Edmunds E,Beevers DG.Should patients with hypertension receive antithrombotic therapy[J].J Intern Med,2001,240 (3):205 -206.
  • 4Fulsome AR.Epidemiology of fibrinogen[J].Eur Heart J,2002,23(Suppl A):21-26.
  • 5Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first- line agents : a network meta - analysis [ J ]. JAMA, 2003,289 (19) :2 534.
  • 6Montgomery AA, Fahey T, Ben Shlomo Y, et al. The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension:a Markov decision analysis [J]. J Hypertens ,2003,21(9) :1 753.
  • 7Cavaleante MA, Bombig MT, Luna Filho B, et al. Quality of life of hypertensive patients treated at an outpatient clinic[J]. Arq Bras Cardio1,2007 ,89( 4 ) :245.
  • 8Baune BT, Aljeesh Y. The association of psychological stress and health related quality of life among patients with stroke and hypertension in Gaza Strip [ J ]. Ann Gen Psychiatry, 2006,19(5) :6.
  • 9Stewart R. Hypertension and depression in late life[J]. Br J Psychiatry, 2006,188 ( 1 ) : 85.
  • 10Alderman MH. Quality of life in hypertensive patients : does it matter and should we measure it [J] ? J Hypertens, 2005,23 (9) : 1 635.

共引文献117

同被引文献94

引证文献7

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部